About Prenatal DNA Sequencing

Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer.

Our analysts forecast the global prenatal DNA sequencing market to grow at a CAGR of 13.50% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global prenatal DNA sequencing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Our report, Global Prenatal DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Agilent Technologies
• BGI
• F. Hoffmann-La Roche
• Illumina
• Laboratory Corporation of America
• Natera

Market driver
• Increasing prevalence of cancer
• For a full, detailed list, view our report

Market challenge
• High cost of sequencing
• For a full, detailed list, view our report

Market trend
• Growing technological improvements in DNA sequencing
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.